APG Asset Management N.V. Acquires 13,967 Shares of Danaher Corporation $DHR

APG Asset Management N.V. lifted its holdings in Danaher Corporation (NYSE:DHR) by 3.5% in the third quarter, according to the company in its most recent filing with the SEC. The fund owned 408,682 shares of the conglomerate’s stock after acquiring an additional 13,967 shares during the quarter. APG Asset Management N.V. owned 0.06% of Danaher worth $81,025,000 at the end of the most recent quarter.

Other institutional investors also recently made changes to their positions in the company. WFA of San Diego LLC purchased a new stake in Danaher during the second quarter valued at about $26,000. Howard Hughes Medical Institute bought a new position in shares of Danaher in the second quarter worth approximately $27,000. ANTIPODES PARTNERS Ltd bought a new stake in Danaher in the 3rd quarter worth $27,000. TruNorth Capital Management LLC bought a new position in shares of Danaher during the third quarter valued at about $28,000. Finally, Tripletail Wealth Management LLC purchased a new stake in Danaher in the 3rd quarter worth approximately $31,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Danaher Price Performance

NYSE DHR opened at $210.28 on Friday. The company has a debt-to-equity ratio of 0.35, a quick ratio of 1.51 and a current ratio of 1.87. The business’s fifty day moving average is $225.33 and its 200 day moving average is $216.23. The company has a market capitalization of $148.70 billion, a PE ratio of 41.72, a price-to-earnings-growth ratio of 2.85 and a beta of 0.91. Danaher Corporation has a fifty-two week low of $171.00 and a fifty-two week high of $242.80.

Danaher (NYSE:DHR) last posted its quarterly earnings data on Tuesday, January 27th. The conglomerate reported $2.23 EPS for the quarter, topping the consensus estimate of $2.14 by $0.09. The firm had revenue of $6.84 billion for the quarter, compared to the consensus estimate of $6.79 billion. Danaher had a return on equity of 10.81% and a net margin of 14.71%.The business’s revenue for the quarter was up 4.6% compared to the same quarter last year. During the same quarter last year, the company earned $2.14 earnings per share. Sell-side analysts predict that Danaher Corporation will post 7.63 earnings per share for the current year.

Danaher Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 24th. Stockholders of record on Friday, March 27th will be given a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a dividend yield of 0.8%. The ex-dividend date is Friday, March 27th. This is a positive change from Danaher’s previous quarterly dividend of $0.32. Danaher’s payout ratio is 25.40%.

Insider Buying and Selling at Danaher

In related news, EVP Gregory M. Milosevich sold 1,320 shares of the company’s stock in a transaction on Thursday, February 19th. The shares were sold at an average price of $208.01, for a total value of $274,573.20. Following the completion of the transaction, the executive vice president owned 5,099 shares of the company’s stock, valued at approximately $1,060,642.99. This represents a 20.56% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Company insiders own 11.10% of the company’s stock.

Analysts Set New Price Targets

DHR has been the subject of several research analyst reports. Wall Street Zen upgraded shares of Danaher from a “hold” rating to a “buy” rating in a report on Saturday, November 22nd. HSBC raised their price objective on shares of Danaher from $255.00 to $270.00 and gave the company a “buy” rating in a research note on Monday, December 1st. Argus set a $265.00 price objective on shares of Danaher in a report on Wednesday, January 14th. Robert W. Baird set a $251.00 price target on Danaher in a research note on Thursday, January 29th. Finally, KeyCorp reissued an “overweight” rating on shares of Danaher in a research report on Thursday, January 29th. Twenty research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $253.86.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.